Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab von Hardy-Werbin, M., Arpí, O., Taus, A., Rocha, P., Joseph-Pietras, D., Nolan, L., Danson, S., Griffiths, R., Lopez-Botet, M., Rovira, A., Albanell, J., Ottensmeier, C. H., Arriola, E.

Volltext

Phase II study of paclitaxel and TAK-228 in metastatic urothelial carcinoma and the impact of PI3K-mTOR pathway genomic alterations von Rodríguez-Vida, A., Pérez-Gracia, J.L., Taus, A., Bonfill, T., Vázquez-Mazón, F.J., Galtes, S., Pons, B., Cano, L., Macia, S., Maroto, P., Bellmunt, J.

Volltext

Homology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA) von Karachaliou, N., Lefterova, M., Draper, J.F., Molina, M.-A., Chaib, I., Palmero, R., Taus, A., Viteri, S., González Cao, M., Majem Tarruella, M., Carcereny Costa, E., Moran, T., Garde Noguera, J., Felip Font, E., Olsen, S., Jackson, M., Sampayo, M., Faull, I., Dix, D., Rosell, R.

Volltext

304 Vanucizumab reduces vessel permeability, perfusion and cellular density of tumor lesions in cancer patients as measured by DCE-MRI and DW-MRI von Nayak, T, Massard, C, Martinez Garcia, M, Le Tourneau, C, Boni, V, Garralda, E, Taus, A, Albanell, J, Lahr, A, Krieter, O, Hidalgo, M

Volltext

Higher PD-L1 expression correlates with lymphocyte infiltration in early non-small cell lung cancer von Rocha, P., Rodrigo, M., Moliner, L., Hardy-Werbin, M., Casadevall Aguilar, D., Durán, X., Arpí, O., Clavé, S., Salido, M., Riera, X., Menendez, S., Taus, Á., Pijuan, L., Comerma, L., Arriola Aperribay, E.

Volltext

Identification of MET gene amplifications using next-generation sequencing in non-small cell lung cancer patients von Clavé, S., Salido, M., Rocha, P., Hardy-Werbin, M., Gibert, J., Riera, X., Weingartner, E., Cerqueira, G., Nichol, D., Simmons, J., Taus, Á, Pijuan, L., Bellosillo, B., Arriola, E.

Volltext

Impact of Lymphopenia on Treatment Outcomes in Unresectable Non-Small Cell Lung Cancer von Amorelli, F., Martinez, A., Liu, F., Foro, P., Algara, M., Sanz, J., Membrive, I., Taus, A., Arriola, E., Masfarré, L., Navarro, N., De Dios, N. Rodriguez

Volltext

Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the 'other epidemic' von Eibl, Joseph K, Morin-Taus, Kristen A, Marsh, David C

Volltext

10P Characterization of chromosomal region 18q in NSCLC KRAS mutant tumors von Clavé, S., Pijuan, L., Casadevall, D., Piquer, G., Rojo, F., Carcereny, E., Taus, Á., Arriola, E., Bellosillo, B., Salido, M.

Volltext

11P Prognostic impact of MET mutations in exon 14 and copy number alterations in a series of NSCLC patients von Clavé, S., Dalmases, A., Longarón, R., Pijuan, L., Casadevall, D., Taus, Á., Espinet, B., Arriola, E., Bellosillo, B., Salido, M.

Volltext

167P KRAS G12C lung adenocarcinoma represents a distinct group of patients with different response to immunotherapy von Masfarré, L., Rocha, P., Clavé, S., Moliner, L., Navarro-Gorro, N., Ríos-Hoyo, A., Sánchez, I., Giner, M., Corbera, A., Taus, A., Bellosillo, B., Arriola, E.

Volltext

193P Differences in response to immunotherapy between KRAS G12C and KRAS non-G12C mutated NSCLC von Pinto, L. Masfarre, Rocha, P., Clave, S., Gorro, N. Navarro, Sanchez, I., Giner, M., Lloret, A. Corbera, Garcia, A. Taus, Parreira, A.S.D.F.M., Paricio, B. Bellosillo, Arriola, E.

Volltext

4P Co-amplifications of PD-L1/PD-L2 genes (9p24.1) and PD-L1 protein expression in NSCLC patients von Clavé, S., Casadevall, D., Pijuan, L., Rodríguez-Rivera, M., García-Moreno, P., Taus, Á., Albanell, J., Espinet, B., Arriola, E., Salido, M.

Volltext

91P Preexisting tumor host immunity delineates clinical outcomes in resectable non-small cell lung cancer von Rocha, P., Rodrigo, M., Moliner, L., Ríos-Hoyo, A., Masfarré, L., Navarro-Gorro, N., Menendez, S., Taus, A., Rodríguez, A., Aguiló, R., Belda, J., Del Rey-Vergara, R., Galindo, M., Comerma, L., Arriola, E.

Volltext

165P SCLC subtypes are associated with distinct dinicopathological features and outcomes: A biomarker analysis from the CANTABRICO study von Rocha, P., Sanchez, I., Pinto, L. Masfarre, Giner, M., Gorro, N. Navarro, Hoyo, A. Rios, Garcia, A. Taus, Pérez-Buira, S., Torres-Fernandez, É., Clave, S., Paricio, B. Bellosillo, Rojo, F., Paz-Ares, L., Cubells, C. Martí, de la Rosa, C. Aguado, Casado, M.D. Isla, Garcia-Campelo, R., Baez, L., Mellén, Á. Callejo, Arriola, E.

Volltext

917TiPPhase II study of paclitaxel and TAK-228 in metastatic urothelial carcinoma and the impact of PI3K-mTOR pathway genomic alterations von Rodríguez-Vida, A, Pérez-Gracia, J L, Taus, A, Bonfill, T, Vázquez-Mazón, F J, Galtes, S, Pons, B, Cano, L, Macia, S, Maroto, P, Bellmunt, J

Volltext

Effectiveness of a Psychoeducational Intervention Group Program in the Reduction of the Burden Experienced by Caregivers of Patients With Dementia: The EDUCA-II Randomized Trial von Martín-Carrasco, Manuel, Domínguez-Panchón, Ana Isabel, González-Fraile, Eduardo, Muñoz-Hermoso, Paula, Ballesteros, Javier

Volltext

P2.01-09 Targetable Genomic Alterations in KRAS Mutant Lung Adenocarcinoma by Targeted Next Generation Sequencing von Arriola, E., Clave, S., Hardy-Werbin, M., Taus, A., Rocha, P., Chaib, I., Carcereny, E., Salido, M., Dalmases, A., Bellosillo, B.

Volltext

O-087 - RADIOTERAPIA INTRAOPERATORIA EN LAS METÁSTASIS CEREBRALES von Martínez, A. Narváez, Arnalot, P. Foro, López, M. Algara, Monino, A. Martínez, García, M. Martínez, García, A. Taus, Barrull, J. Vidal, Mármol, B. Beltran, Font, J. Capellades, Sánchez, J.F., Santos, N. Infante, Vega, V. Calvet, Hernández, F. Muñoz, Martínez, G. Villalba

Volltext

Evaluation of tumor- and stromal immune marker heterogeneity in non-small cell lung cancer von Aguilar, D. Casadevall, Pijuan, L., Clave, S., Taus, A., Hernández, A., Lorenzo, M., Mojal, S., Menéndez, S., Albanell, J., Salido, M., Arriola, E.

Volltext